Paper10073983
Lipid and apolipoprotein predictors of atherosclerosis in youth: apolipoprotein concentrations do not materially improve prediction of arterial lesions in PDAY subjects. The PDAY Research Group.
Rainwater DL and 6 others. Arterioscler Thromb Vasc Biol, 1999. Cited by 39 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Lipid and apolipoprotein predictors of atherosclerosis in youth: apolipoprotein concentrations do not materially improve prediction of arterial lesions in PDAY subjects. The PDAY Research Group. Papers, record 10073983. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/10073983
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Lipid and apolipoprotein predictors of atherosclerosis in youth: apolipoprotein concentrations do not materially improve prediction of arterial lesions in PDAY subjects. The PDAY Research Group.
- PubMed
Topics18
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Apolipoproteins A | Major topic |
| Apolipoproteins B | Major topic |
| Arteriosclerosis | Major topic |
| Cholesterol, HDL | Major topic |
| Adolescent | |
| Adult | |
| Age Distribution | |
| Aorta | |
| Endothelium, Vascular | |
| Female | |
| Humans | |
| Hypertension | |
| Lipoprotein(a) | |
| Male | |
| Predictive Value of Tests | |
| Risk Factors | |
| Sex Distribution | |
| Smoking |
Source PubMed
Grants4
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| HL-33733 | NHLBI NIH HHS | United States | R10HL033733 | PubMed and NIH | NIH RePORTER |
| HL-33750 | NHLBI NIH HHS | United States | R01HL033750 | PubMed and NIH | NIH RePORTER |
| HL-33765 | NHLBI NIH HHS | United States | R10HL033765 | PubMed and NIH | NIH RePORTER |
| R10HL033750 | NIH | NIH RePORTER |
Trials1
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
| Trial | Title | The trial lists it as | Named in the paper's record |
|---|---|---|---|
| NCT00005679 | Pathobiological Determinants of Atherosclerosis in Youth (PDAY) | Background |
Source ClinicalTrials.gov
Cited by9
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 39 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 36959504 | Pediatric dyslipidemia is associated with increased urinary ACE activity, blood pressure values, and carotidal-femoral pulse wave velocity. | Hypertens Res | 2023 | https://conductscience.org/library/papers/36959504 | PubMed |
| 32795477 | Relationship of Apolipoproteins with Subclinical Cardiovascular Risk in Youth. | J Pediatr | 2020 | https://conductscience.org/library/papers/32795477 | PubMed |
| 29204335 | Temporal trends in lipid testing among children and adolescents: A population based study. | Prev Med Rep | 2017 | https://conductscience.org/library/papers/29204335 | PubMed |
| 27366705 | Triglyceride and cardiovascular risk: A critical appraisal. | Indian J Endocrinol Metab | 2016 | https://conductscience.org/library/papers/27366705 | PubMed |
| 26136629 | Prediction of 10-year risk of hard coronary events among Saudi adults based on prevalence of heart disease risk factors. | J Saudi Heart Assoc | 2015 | https://conductscience.org/library/papers/26136629 | PubMed |
| 24904843 | The current state of dyslipidemia in Korean children and adolescents and its management in clinical practice. | Ann Pediatr Endocrinol Metab | 2013 | https://conductscience.org/library/papers/24904843 | PubMed |
| 24174878 | Molecular sources of residual cardiovascular risk, clinical signals, and innovative solutions: relationship with subclinical disease, undertreatment, and poor adherence: implications of new evidence upon optimizing cardiovascular patient outcomes. | Vasc Health Risk Manag | 2013 | https://conductscience.org/library/papers/24174878 | PubMed |
| 23460684 | Triglyceride to HDL-C ratio and increased arterial stiffness in children, adolescents, and young adults. | Pediatrics | 2013 | https://conductscience.org/library/papers/23460684 | PubMed |
| 23293697 | Cardiovascular Risk in Children and Adolescents with Type 1 and Type 2 Diabetes Mellitus. | Curr Cardiovasc Risk Rep | 2012 | https://conductscience.org/library/papers/23293697 | PubMed |
Genes2
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| APOA1 | 335 | PubTator's text mining | https://conductscience.org/library/genes/335 | NCBI Gene |
| APOB | 338 | PubTator's text mining | https://conductscience.org/library/genes/338 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Comments and corrections
- References
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/10073983
GET https://conductscience.org/api/papers/v1/10073983/authors